The Future is Now: Virtual Clinical Trials Transforming Drug Development Blog The Future is Now: Virtual Clinical Trials Transforming Drug Development Welcome to the forefront of drug development innovation! The drug development landscape is rapidly evolving,…CertaraJune 4, 2024
Phoenix UGM 2024: A Day of Innovation and Collaboration Blog Phoenix UGM 2024: A Day of Innovation and Collaboration The Phoenix UGM featured industry expert insights, peer networking, and glimpses into the latest PK/PD…CertaraMay 31, 2024
Demystifying CDISC, SDTM, and ADaM Blog Demystifying CDISC, SDTM, and ADaM Breaking down the basics of CDISC’s CDASH, SDTM and ADaM standards, to help you understand…CertaraMay 22, 2024
Leveling Up SDTM Validation with the Magic of Data Managers Blog Leveling Up SDTM Validation with the Magic of Data Managers In this abstract, Julie Ann Hood and Jennifer Manzi look at how you can improve…CertaraMay 19, 2024
Reflections on the New FDA Clinical Pharmacology Guidance for Antibody-Drug Conjugates Blog Reflections on the New FDA Clinical Pharmacology Guidance for Antibody-Drug Conjugates In recent years, oncology drug developers have invested in antibody-drug conjugates (ADCs). These targeted therapies…CertaraMay 10, 2024
Why are Clinical Data Standards Essential for EDC and Non-EDC Data? Blog Why are Clinical Data Standards Essential for EDC and Non-EDC Data? Clinical data standards are essential for both EDC & non-EDC data. Learn how study build…CertaraApril 25, 2024
Latest PBPK Modeling Platform Advances Drug Development Blog Latest PBPK Modeling Platform Advances Drug Development In the ever-evolving pharmaceutical landscape, advancing drug development requires innovative tools that seamlessly integrate science…CertaraApril 23, 2024
What are biosimilars & how are they developed? Blog What are biosimilars & how are they developed? Learn about biosimilars, their benefits for patients who take biologic drugs, and how pharmaceutical companies…CertaraApril 15, 2024
An Endogenous Biomarker for Predicting OATP1B DDIs Blog An Endogenous Biomarker for Predicting OATP1B DDIs This blog reviews the role of the endogenous biomarker, CP-1, for assessing OATP1B transporter-mediated drug-drug…CertaraApril 5, 2024
What Should a Clinical Metadata Repository Do? Blog What Should a Clinical Metadata Repository Do? April 4, 2024 As the clinical research industry moves towards more efficient and automated processes, clinical…CertaraApril 4, 2024